ClinicalTrials.gg
Not yet recruitingNCT06586190Updated Oct 26, 2026

Outpatient Floor Pedal Bike Utilization

An interventional study of Floor Pedal Bike with Guided Instructions for Home in Femur Fracture, Tibia Fracture and Ankle Injuries, sponsored by Wake Forest University Health Sciences. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-26.

Sponsored by Wake Forest University Health Sciences · Not applicable, Interventional, and Other

Updated Oct 26, 2026Start date movedGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

The goals of this clinical trial are: to test the feasibility of identifying patients and getting patients the floor pedal bikes, to test how well floor pedal bikes help patients with lower body injuries heal, and to test methods of patient self-reported logs for home pedal bike use.

Participants will be given a floor pedal bike at first post-operative appointment where weightbearing restrictions are lifted (weight-bearing as tolerated) along with instructions on utilization. Participants will be asked to complete patient reported outcome measure surveys at each follow-up visit.

Read the detailed description

The goals of this clinical trial are:

  1. to test the feasibility of identifying patients and getting patients the floor pedal bikes themselves
  2. to test the efficacy of floor pedal bikes in the rehabilitation of patients with lower extremity orthopedic trauma injuries without formal physical therapy or as a supplement to preexisting and/or future physical therapy. We hope that these bikes will either supplement patient's preexisting therapy or allow them to complete therapy at home if they are unable to obtain formal physical therapy and
  3. to test various methods of patient self-reported logs for home pedal bike utilization, whether electronic or hard paper copy.

Participants will be given a floor pedal bike at first post-operative appointment where weightbearing restrictions are lifted (weight-bearing as tolerated) along with instructions on utilization. Participants will be asked to complete patient reported outcome measure surveys at each follow-up visit.

02

Conditions studied

  • Femur Fracture
  • Tibia Fracture
  • Ankle Injuries

Keywords

  • floor pedal bike
  • lower extremity
  • rehabilitation
03

In context

Femoral Fractures

186 studies on the registry are indexed under Femoral Fractures; 38 are open to participants now.

This study's planned enrollment of 20 is below the median of 61 across 114 interventional studies indexed under Femoral Fractures.

Browse Femoral Fractures studies →

Lead sponsor

Wake Forest University Health Sciences is the lead sponsor of 1,351 studies on the registry; 201 are open to participants now.

Of its 332 completed or terminated interventional studies of FDA-regulated products, 251 (76%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients >18 years of age
  • Operative fractures of the femur, tibia and select ankle injuries
  • Under the care of an orthopaedic surgeon
  • English or Spanish competent
  • 12 month follow up

Exclusion criteria

Exclusion Criteria:

  • Type IIIB/C fracture
  • Unable to provide consent/need for an LAR
  • Major lower extremity peripheral nerve injury (ex. foot drop, sciatic nerve palsy, etc)
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
20 participants (estimated)

Study arms

  • Other
    Observational Arm

    Patients with lower extremity traumatic injuries that are medically clear for physically ready for therapy and will receive a floor pedal bike with guided exercises at home.

    Other: Floor Pedal Bike with Guided Instructions for Home

Interventions

  • OtherFloor Pedal Bike with Guided Instructions for Home

    Patients with lower extremity traumatic injuries that are medically clear for physically ready for therapy and will receive a floor pedal bike with guided exercises at home.

06

What researchers measure

Primary outcomes

  1. Return to Work/Functional Activity

    The primary assessment tool will be the International Physical Activity Questionnaire. IPAQ measures the total amount of physical activity completed in a 7 day period by calculating the minutes per week in in each physical activity level domain (walking, moderate and vigorous) by a metabolic equivalent energy (MET) expenditure estimate. Walking = 3.3 x number of walking minutes x number of walking days Moderate activity= 4.0 x number activity minutes x number of days Vigorous activity = 8 x number of activity minutes x number of days Total = Walking MET-min/wk+moderate MET-min/wk+vigorous MET-min/wk

    Time frame: Baseline, 3, 6, 12 months

Secondary outcomes

  1. Connor-Davidson Resilience Scale (CD-RISC)

    Scores range between 0-100. Higher scores indicate higher resilience.

    Time frame: Baseline, 3, 6, 12 months

  2. Tampa Scale for Kinesiophobia (TSK)

    This scale is 17 items and uses a 4-point Likert scale ranging from 'strongly disagree' to 'strongly agree'. The TSK is a validated measure for surgical and musculoskeletal patients. The 17 item TSK total scores range from 17 to 68 where the lowest 17 means no or negligible kinesiophobia, and the higher scores indicate an increasing degree of kinesiophobia

    Time frame: Baseline, 3, 6, 12 months

  3. Pain Catastrophizing Scale (PCS)

    Scores range between 0-52. A higher score indicates a greater degree or pain catastrophizing.

    Time frame: Baseline, 3, 6, 12 months

  4. Veterans RAND 12 Item Health Survey (VR-12)

    Patients will complete the Veterans RAND 12 Item Health Survey (VR12).The VR-12 is a measure of global health that corresponds to seven domains: general health, physical functioning, role limitations, pain, fatigue, social functioning, and mental health. Scores range from 0 to 100, where a zero score indicates the lowest level of health and 100 indicates the highest level of health.

    Time frame: Baseline, 3, 6, 12 months

  5. PROMIS Pain Interference Short Form

    Scores range from 8 to 40. A higher score indicates greater pain interference.

    Time frame: 3, 6, 12 months

  6. PROMIS Physical Function Short Form

    T-scores range from 14.1 to 61.7. T-scores of 14.1-30.0 represent severe impairment, 30.0-40.0 represent moderate impairment, 40.0-45.0 represent mild impairment, and 45.0-61.7 indicate no impairment

    Time frame: 3, 6, 12 months

  7. Brief Pain Inventory (BPI)

    The BPI is a commonly used and validated 15-item measure of pain intensity and interference with daily life. Score: 1 - 4 = Mild Pain. Worst Pain Score: 5 - 6 = Moderate Pain. Worst Pain Score: 7 - 10 = Severe Pain.

    Time frame: 3, 6, 12 months

  8. Performance test - Timed up and go test

    Participants begin in a seated position. They are directed to stand and walk 3 meters to a cone on the floor. They are to round the cone in a continuous motion, walk back to the chair, turn again and be seated. The entire test is performed at a comfortable and safe speed for the patient. The data are captured by an Attitude and Heading Reference System (AHRS). Custom software has been developed to appropriately filter the raw data, establish a fixed global coordinate system (i.e. aligned with the body coordinate system), segregate gait segment data from turn data, and delineate and compile data for left and right strides for separate analyses.

    Time frame: 3, 6, 12 months

  9. Performance test - Five time sit to stand test

    Participants begin from a seated position and are directed to come to a full standing position without push off assistance from upper extremities and then return to a seated position without upper extremity assist. The test pattern is repeated 5 times. The data are captured by an Attitude and Heading Reference System (AHRS) that is chest-mounted and positioned at the top of the sternum using a simple harness. Custom software has been developed to appropriately filter the raw data, establish a fixed global coordinate system (i.e. aligned with the body coordinate system), segregate gait segment data from turn data, and delineate and compile data for left and right strides for separate analyses.

    Time frame: 3, 6, 12 months

  10. Performance test - 10 meter walk test (Gait)

    Participants complete a modified 10 meter walk test which involves the subject starting from a standing position, walking 5 meters at a comfortable pace, turning around, and then walking back 5 meters to the original starting point. The test is repeated twice for each subject. The data are captured by an Attitude and Heading Reference System (AHRS) that is chest-mounted and positioned at the top of the sternum using a simple harness. Custom software has been developed to appropriately filter the raw data, establish a fixed global coordinate system (i.e. aligned with the body coordinate system), segregate gait segment data from turn data, and delineate and compile data for left and right strides for separate analyses.

    Time frame: 3, 6, 12 months

07

Study locations

No study locations are listed for this record.

08

Updates

1 registry update since Sep 25, 2026
Start date
Oct 2026→Jan 2027
Oct 26, 2026
Show all 1 update
  1. Oct 26, 2026
    Start date Oct 2026→Jan 2027

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT06586190
Responsible party
Sponsor
First posted
Sep 19, 2024
Start date
Jan 2027 (estimated)
Primary completion
Dec 2028 (estimated)
Completion
Dec 2028 (estimated)
Last update
Oct 26, 2026

Study contacts

Christine Churchill, MA
Contact
christine.churchill@advocatehealth.org
704-355-6947
Rachel B Seymour, PhD
Contact
Rachel.Seymour@advocatehealth.org
704-355-6969
Joseph Hsu, MD
principal investigator · Wake Forest University Health Sciences

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in May 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion